Showing results (21-30 of 106) with videos related to
Sort By:
Pageof 11
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in childrenAmeeta Mehta, Peter C Hindmarsh, Richard G Stanhope, et al.Cancer Chemotherapy and Pharmacology|April 27, 2011
Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patientsKeyvan Rezai, S Urien, N Isambert, et al.International Journal of MS Care|November 3, 2016
The Transition to Secondary Progressive Multiple Sclerosis: An Exploratory Qualitative Study of Health Professionals' ExperiencesFreya Davies, Fiona Wood, Katherine E Brain, et al.British Journal of Cancer|June 1, 2006
A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancerL Zelek, A Yovine, E Brain, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2009
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancerF-C Bidard, C Mathiot, S Delaloge, et al.European Journal of Pediatrics|May 13, 2016
Management of Cushing syndrome in children and adolescents: experience of a single tertiary centreMaria Güemes, Philip G Murray, Caroline E Brain, et al.Hormone Research|September 30, 2005
Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's diseaseJ E Greening, C E Brain, L A Perry, et al.British Journal of Cancer|November 2, 2013
Recognition of cancer warning signs and anticipated delay in help-seeking in a population sample of adults in the UKS L Quaife, L J L Forbes, A J Ramirez, et al.Journal of Clinical Pathology|May 1, 1997
Girls with virilisation in childhood: a diagnostic protocol for investigationM E Street, A Weber, C Camacho-Hübner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumorsA Taamma, J L Misset, M Riofrio, et al.Pageof 11